Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 3
1966 5
1967 1
1968 8
1969 6
1970 2
1971 5
1972 8
1973 7
1974 12
1975 12
1976 3
1977 3
1978 7
1979 11
1980 8
1981 5
1982 6
1983 7
1984 13
1985 16
1986 10
1987 14
1988 10
1989 17
1990 33
1991 24
1992 34
1993 27
1994 44
1995 47
1996 47
1997 52
1998 66
1999 69
2000 66
2001 50
2002 66
2003 68
2004 64
2005 63
2006 85
2007 88
2008 61
2009 70
2010 77
2011 101
2012 98
2013 123
2014 102
2015 129
2016 129
2017 98
2018 84
2019 91
2020 69
2021 50
2022 39
2023 32
2024 31
2025 22
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,398 results

Results by year

Filters applied: . Clear all
Page 1
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.
Pengo V, Denas G, Zoppellaro G, Jose SP, Hoxha A, Ruffatti A, Andreoli L, Tincani A, Cenci C, Prisco D, Fierro T, Gresele P, Cafolla A, De Micheli V, Ghirarduzzi A, Tosetto A, Falanga A, Martinelli I, Testa S, Barcellona D, Gerosa M, Banzato A. Pengo V, et al. Blood. 2018 Sep 27;132(13):1365-1371. doi: 10.1182/blood-2018-04-848333. Epub 2018 Jul 12. Blood. 2018. PMID: 30002145 Free article. Clinical Trial.
Rivaroxaban is an effective and safe alternative to warfarin in patients with atrial fibrillation and venous thromboembolism. We tested the efficacy and safety of rivaroxaban compared with warfarin in high-risk patients with thrombotic antiphospholipid syndrome. ... …
Rivaroxaban is an effective and safe alternative to warfarin in patients with atrial fibrillation and venous thromboembolism. We test …
Apixaban vs. warfarin in patients with left ventricular thrombus: a prospective multicentre randomized clinical trial .
Alcalai R, Butnaru A, Moravsky G, Yagel O, Rashad R, Ibrahimli M, Planer D, Amir O, Elbaz-Greener G, Leibowitz D. Alcalai R, et al. Eur Heart J Cardiovasc Pharmacother. 2022 Sep 29;8(7):660-667. doi: 10.1093/ehjcvp/pvab057. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 34279598 Free article. Clinical Trial.
In the warfarin group, two patients withdrew, and in the apixaban group one patient died. Thrombus completely resolved in 14 of 15 patients in the warfarin group and in 16 of 17 patients in the apixaban group (P = NS and P = 0.026 for non-inferiority). Two patients …
In the warfarin group, two patients withdrew, and in the apixaban group one patient died. Thrombus completely resolved in 14 of 15 pa …
Randomized Controlled: Trial of New Oral Anticoagulants Versus Warfarin for Postcardiac Surgery Atrial Fibrillation: The NEW-AF Trial.
Moonsamy P, Zhao Y, Makarem A, Paneitz DC, Wolfe S, Turco I, Colon KM, Ethridge BR, Li SS, Leya G, Verma S, D'Alessandro DA, Jassar AS, Langer NB, Tolis G, Villavicencio MA, Melnitchouk SI, Bloom JP, Michel E, Kreso A, Rabi SA, Akeju O, Sundt TM, Osho AA. Moonsamy P, et al. Ann Surg. 2025 Oct 1;282(4):630-638. doi: 10.1097/SLA.0000000000006853. Epub 2025 Jul 24. Ann Surg. 2025. PMID: 40704706 Clinical Trial.
OBJECTIVE: To determine whether anticoagulation for new onset atrial fibrillation (AF) with rivaroxaban decreases length of stay compared with warfarin. SUMMARY OF BACKGROUND DATA: Direct Oral Anticoagulants (DOACs) have been shown to be noninferior to warfarin for …
OBJECTIVE: To determine whether anticoagulation for new onset atrial fibrillation (AF) with rivaroxaban decreases length of stay compared wi …
A randomized controlled trial of dabigatran versus warfarin for periablation anticoagulation in patients undergoing ablation of atrial fibrillation.
Nin T, Sairaku A, Yoshida Y, Kamiya H, Tatematsu Y, Nanasato M, Inden Y, Hirayama H, Murohara T. Nin T, et al. Pacing Clin Electrophysiol. 2013 Feb;36(2):172-9. doi: 10.1111/pace.12036. Epub 2012 Nov 4. Pacing Clin Electrophysiol. 2013. PMID: 23121681 Clinical Trial.
A bridging therapy with heparin was not used in either of the patient groups. RESULTS: Dabigatran was switched to warfarin before the ablation because of dyspepsia in three patients. An occurrence of rebleeding from the venipuncture site was less common in dabigatran-alloc …
A bridging therapy with heparin was not used in either of the patient groups. RESULTS: Dabigatran was switched to warfarin before the …
Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial.
Mega JL, Walker JR, Ruff CT, Vandell AG, Nordio F, Deenadayalu N, Murphy SA, Lee J, Mercuri MF, Giugliano RP, Antman EM, Braunwald E, Sabatine MS. Mega JL, et al. Lancet. 2015 Jun 6;385(9984):2280-7. doi: 10.1016/S0140-6736(14)61994-2. Epub 2015 Mar 11. Lancet. 2015. PMID: 25769357 Clinical Trial.
We tested whether genetic variants can identify patients who are at increased risk of bleeding with warfarin and, consequently, those who would derive a greater safety benefit with a direct oral anticoagulant rather than warfarin. ...After 90 days, the reduction in …
We tested whether genetic variants can identify patients who are at increased risk of bleeding with warfarin and, consequently, those …
Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial.
Zambon CF, Pengo V, Moz S, Bozzato D, Fogar P, Padoan A, Plebani M, Groppa F, De Rosa G, Padrini R. Zambon CF, et al. Eur J Clin Pharmacol. 2018 May;74(5):571-582. doi: 10.1007/s00228-018-2422-8. Epub 2018 Feb 2. Eur J Clin Pharmacol. 2018. PMID: 29396738 Clinical Trial.
PURPOSE: A previous trial failed to demonstrate the superiority of a demographic-genetic algorithm in predicting warfarin (W) dose over a standard clinical approach. The purpose of the present study is to re-analyse the results in subgroups of patients with differing basel …
PURPOSE: A previous trial failed to demonstrate the superiority of a demographic-genetic algorithm in predicting warfarin (W) dose ov …
Warfarin and stroke.
Bohr T. Bohr T. West J Med. 1989 Dec;151(6):669. West J Med. 1989. PMID: 2694623 Free PMC article. Clinical Trial. No abstract available.
Warfarin versus aspirin prevents portal vein thrombosis after laparoscopic splenectomy and azygoportal disconnection: A randomized clinical trial.
Bai DS, Xia BL, Zhang C, Ye J, Qian JJ, Jin SJ, Jiang GQ. Bai DS, et al. Int J Surg. 2019 Apr;64:16-23. doi: 10.1016/j.ijsu.2019.02.018. Epub 2019 Mar 6. Int J Surg. 2019. PMID: 30851458 Free article. Clinical Trial.
The aim of this study is to evaluate the safety and efficacy of warfarin in preventing PVST after laparoscopic splenectomy and azygoportal disconnection (LSD). ...Warfarin treatment was associated with better liver function protection and renal function improvement …
The aim of this study is to evaluate the safety and efficacy of warfarin in preventing PVST after laparoscopic splenectomy and azygop …
Effects of patupilone on the pharmacokinetics and pharmacodynamics of warfarin in patients with advanced malignancies: a phase I clinical trial.
Tsimberidou AM, Takimoto CH, Moulder S, Uehara C, Mita M, Mita A, Urban P, Tan E, Wang Y, Vining D, Kurzrock R. Tsimberidou AM, et al. Mol Cancer Ther. 2011 Jan;10(1):209-17. doi: 10.1158/1535-7163.MCT-10-0774. Mol Cancer Ther. 2011. PMID: 21220503 Clinical Trial.
Pharmacokinetics, pharmacodynamics, and safety of warfarin when administered concomitantly with patupilone were investigated, and antitumor activity was assessed. ...The pharmacokinetics and pharmacodynamics of warfarin were not affected by patupilone coadministrati …
Pharmacokinetics, pharmacodynamics, and safety of warfarin when administered concomitantly with patupilone were investigated, and ant …
Venous thromboembolism.
Spaulding C. Spaulding C. J Fam Pract. 1995 Dec;41(6):604-5. J Fam Pract. 1995. PMID: 7500073 Clinical Trial. No abstract available.
2,398 results